type 2 diabetes

Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Clinical Trials Arena
Eli Lilly
retatrutide
clinical trials
NASH
obesity
diabetes
type 2 diabetes
Flag link:
TheracosBio reports data from trial of diabetes therapy
TheracosBio reports data from trial of diabetes therapy
Clinical Trials Arena
TheracosBio
diabetes
type 2 diabetes
Brenzavvy
clinical trials
Flag link:
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
Benzinga
Eli Lilly
Boehringer Ingelheim
Jardiance
Synjardy
type 2 diabetes
pediatric
FDA
Flag link:
AstraZeneca drops another GLP-1 after phase 1 data bust market-beating diabetes hopes
AstraZeneca drops another GLP-1 after phase 1 data bust market-beating diabetes hopes
Fierce Biotech
AstraZeneca
GLP-1 agonist
AZD0186
type 2 diabetes
Flag link:
Eli Lilly’s Mounjaro likely to become ‘leading therapy’ for obesity and type 2 diabetes
Eli Lilly’s Mounjaro likely to become ‘leading therapy’ for obesity and type 2 diabetes
Biopharma Reporter
Eli Lilly
Mounjaro
obesity
type 2 diabetes
Flag link:
With TheracosBio green light, another SGLT2 inhibitor wades into diabetes arena
With TheracosBio green light, another SGLT2 inhibitor wades into diabetes arena
Fierce Pharma
bexaglifozin
diabetes
FDA
Brenzavvy
type 2 diabetes
Theracos
Flag link:
Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Endpoints
Novo Nordisk
Rybelsus
semaglutide
FDA
type 2 diabetes
diabetes
Flag link:
Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%
Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%
Fierce Biotech
Oramed
diabetes
type 2 diabetes
clinical trials
insulin
oral insulin
ORMD-0801
Flag link:
Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win
Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win
BioSpace
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
Jardiance
pediatri
Flag link:
Eli Lilly tightens access to diabetes drug, frustrating some people with obesity
Eli Lilly tightens access to diabetes drug, frustrating some people with obesity
Stat
Eli Lilly
type 2 diabetes
obesity
Mounjaro
social media
Flag link:
Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025
Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025
Fierce Pharma
Eli Lilly
Mounjaro
diabetes
type 2 diabetes
obesity
drug manufacturing
Flag link:
Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report
Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report
Endpoints
Eli Lilly
Mounjaro
diabetes
type 2 diabetes
drug manufacturing
Flag link:
Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics
Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics
Medtech Dive
Medtech
devices
Tandem Diabetes
DexCom
type 2 diabetes
CGM
t:slim X2
Flag link:
Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
Xtalks
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
type 2 diabetes
Flag link:
With Lilly's Mounjaro set for stardom, an Alzheimer's win would be 'icing on the cake': analysts
With Lilly's Mounjaro set for stardom, an Alzheimer's win would be 'icing on the cake': analysts
Fierce Pharma
Eli Lilly
type 2 diabetes
obesity
donanemab
Mounjaro
Alzheimer's disease
Flag link:
Novo's Once-Weekly Insulin Treatment Part of a Transforming T2D Space
Novo's Once-Weekly Insulin Treatment Part of a Transforming T2D Space
BioSpace
Novo Nordisk
clinical trials
type 2 diabetes
diabetes
insulin icodec
Flag link:
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes
Yahoo Finance
Novo Nordisk
clinical trials
CagriSema
semaglutide
diabetes
type 2 diabetes
Flag link:
Innovent & Eli Lilly's Type 2 Diabetes Drug Lowers HbA1c, Scores Early Win
Innovent & Eli Lilly's Type 2 Diabetes Drug Lowers HbA1c, Scores Early Win
BioSpace
Innovent
Eli Lilly
type 2 diabetes
diabetes
mazdutide
clinical trials
Flag link:
Cialis may have new benefit in men with diabetes, but not women, study shows
Cialis may have new benefit in men with diabetes, but not women, study shows
Stat
Cialis
diabetes
type 2 diabetes
erectile dysfunction
Flag link:
Lilly's highly anticipated diabetes drug Mounjaro wins FDA blessing
Lilly's highly anticipated diabetes drug Mounjaro wins FDA blessing
Fierce Pharma
Eli Lilly
Mounjaro
tirzepatide
FDA
diabetes
type 2 diabetes
Flag link:

Pages